Superior vena cava syndrome: Difference between revisions
No edit summary |
No edit summary |
||
| Line 32: | Line 32: | ||
##Effective if pt has steroid-responsive malignancy (e.g. lymphoma, thymoma) | ##Effective if pt has steroid-responsive malignancy (e.g. lymphoma, thymoma) | ||
#Loop diuretic | #Loop diuretic | ||
## | ##Controversial | ||
#Mediastinal radiation | #Mediastinal radiation | ||
#Intravascular stent | #Intravascular stent | ||
Revision as of 01:17, 23 October 2011
Background
- External compression by extrinsic malignant mass causes majority of cases
- Rarely constitutes an emergency
- Gradual process; collaterals dilate to compensate for the impaired flow
- Exception is neurologic abnormalities due to increased ICP
- Risk Factors:
- Lung Cancer
- Lymphoma
- Indwelling vascular catheters
Clinical Features
- Facial swelling
- Dyspnea
- Cough
- Arm swelling
- Distended neck/chest wall veins
- Neurologic abnormalities (rare)
- Visual changes
- Dizziness
- Confusion
- Seizure
Diagnosis
- CT w/ IV contrast
- Recommended imaging modality (assesses patency of the SVC)
- CXR
- Shows mediastinal mass or paranchymal lung mass (10% of pts)
Treatment
- Elevate head of bed
- Corticosteroids
- Effective if pt has steroid-responsive malignancy (e.g. lymphoma, thymoma)
- Loop diuretic
- Controversial
- Mediastinal radiation
- Intravascular stent
Source
Tintinalli
